Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness

Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness

Objectives: To assess the characteristics and risk factors for mortality in patients with severe coronavirus disease-2019 (COVID-19) treated with tocilizumab (TCZ), alone or in combination with corticosteroids (CS). Methods: From March 17 to April 7, 2020, a real-world observational retrospective an...

Full description

Bibliographic Details
Main Authors: Manuel Rubio-Rivas, Mar Ronda, Ariadna Padulles, Francesca Mitjavila, Antoni Riera-Mestre, Carlos García-Forero, Adriana Iriarte, Jose M. Mora, Nuria Padulles, Monica Gonzalez, Xavier Solanich, Merce Gasa, Guillermo Suarez-Cuartin, Joan Sabater, Xose L. Perez-Fernandez, Eugenia Santacana, Elisabet Leiva, Albert Ariza-Sole, Paolo D. Dallaglio, Maria Quero, Antonio Soriano, Alberto Pasqualetto, Maylin Koo, Virginia Esteve, Arnau Antoli, Rafael Moreno-Gonzalez, Sergi Yun, Pau Cerda, Mariona Llaberia, Francesc Formiga, Marta Fanlo, Abelardo Montero, David Chivite, Olga Capdevila, Ferran Bolao, Xavier Pinto, Josep Llop, Antoni Sabate, Jordi Guardiola, Josep M. Cruzado, Josep Comin-Colet, Salud Santos, Ramon Jodar, Xavier Corbella
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:International Journal of Infectious Diseases
Subjects:
COVID-19
Tocilizumab
Corticosteroids
Systemic inflammation
Mortality
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220322025

Internet

http://www.sciencedirect.com/science/article/pii/S1201971220322025

Similar Items